Copyright
©2010 Baishideng.
World J Diabetes. Mar 15, 2010; 1(1): 3-7
Published online Mar 15, 2010. doi: 10.4239/wjd.v1.i1.3
Published online Mar 15, 2010. doi: 10.4239/wjd.v1.i1.3
Table 1 Pharmacological profile of oral PDE5-i at therapeutic dosage for ED
| Parameter | Sildenafil 100 mg | Tadalafil 20 mg | Vardenafil 20 mg |
| Tmax (h) | 1.16 ± 0.99 | 2 | 0.66 (0.250-3.0) |
| T1/2 (h) | 3.82 ± 0.84 | 17.5 | 3.94 ± 1.31 |
| C (max ng/m) | 327 ± 236 | 378 | 20.9 ± 1.83 |
| AUC (ng × h/m) | 1963 ± 859 | 8066 | 74.5 ± 1.82 |
- Citation: Aversa A. Systemic and metabolic effects of PDE5-inhibitor drugs. World J Diabetes 2010; 1(1): 3-7
- URL: https://www.wjgnet.com/1948-9358/full/v1/i1/3.htm
- DOI: https://dx.doi.org/10.4239/wjd.v1.i1.3